RYSDEO MYCITE Trademark

Trademark Overview


On Wednesday, June 24, 2020, a trademark application was filed for RYSDEO MYCITE with the United States Patent and Trademark Office. The USPTO has given the RYSDEO MYCITE trademark a serial number of 79292766. The federal status of this trademark filing is REGISTERED as of Tuesday, August 10, 2021. This trademark is owned by Otsuka Pharmaceutical Co., Ltd.. The RYSDEO MYCITE trademark is filed in the Pharmaceutical Products and Medical Instrument Products categories with the following description:

Pharmaceutical preparations for the treatment of central nervous system diseases and disorders; pharmaceutical preparations for the treatment of central nervous system diseases and disorders in the form of ingestible tablets and pills containing silicon sensor chips; pharmaceutical preparations for the treatment of central nervous system diseases and disorders, containing silicon sensor chips which transmit information about drug ingestion by the patient

Medical apparatus and instruments for monitoring vital signs of patients; medical diagnostic apparatus and instruments for monitoring vital signs of patients; patient monitoring sensors and alarms; sensor apparatus for medical use in monitoring the vital signs of patients; sensor devices and medical apparatus all for medical use, namely, sensor patches attached to a patient's body for use in measuring, collecting, storing and transmitting patient data and medical information in the nature of drug ingestion information, pulse, heart rate, respiratory rate, body temperature, electric pressure in the body, human motion, human position and sleeping condition
rysdeo mycite

General Information


Serial Number79292766
Word MarkRYSDEO MYCITE
Filing DateWednesday, June 24, 2020
Status700 - REGISTERED
Status DateTuesday, August 10, 2021
Registration Number6443522
Registration DateTuesday, August 10, 2021
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 25, 2021

Trademark Statements


Goods and ServicesPharmaceutical preparations for the treatment of central nervous system diseases and disorders; pharmaceutical preparations for the treatment of central nervous system diseases and disorders in the form of ingestible tablets and pills containing silicon sensor chips; pharmaceutical preparations for the treatment of central nervous system diseases and disorders, containing silicon sensor chips which transmit information about drug ingestion by the patient
Goods and ServicesMedical apparatus and instruments for monitoring vital signs of patients; medical diagnostic apparatus and instruments for monitoring vital signs of patients; patient monitoring sensors and alarms; sensor apparatus for medical use in monitoring the vital signs of patients; sensor devices and medical apparatus all for medical use, namely, sensor patches attached to a patient's body for use in measuring, collecting, storing and transmitting patient data and medical information in the nature of drug ingestion information, pulse, heart rate, respiratory rate, body temperature, electric pressure in the body, human motion, human position and sleeping condition

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, September 11, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateFriday, September 11, 2020
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameOtsuka Pharmaceutical Co., Ltd.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressJP

Party NameOtsuka Pharmaceutical Co., Ltd.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressJP

Party NameOtsuka Pharmaceutical Co., Ltd.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressJP

Trademark Events


Event DateEvent Description
Monday, March 13, 2023NEW REPRESENTATIVE AT IB RECEIVED
Monday, February 14, 2022FINAL DECISION TRANSACTION PROCESSED BY IB
Thursday, January 20, 2022FINAL DISPOSITION NOTICE SENT TO IB
Thursday, January 20, 2022FINAL DISPOSITION PROCESSED
Wednesday, November 10, 2021FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, August 10, 2021REGISTERED-PRINCIPAL REGISTER
Tuesday, May 25, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 25, 2021PUBLISHED FOR OPPOSITION
Sunday, May 23, 2021NOTIFICATION PROCESSED BY IB
Wednesday, May 5, 2021NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, May 5, 2021NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, May 5, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, April 16, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, April 15, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, April 15, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, April 15, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Saturday, November 14, 2020REFUSAL PROCESSED BY IB
Wednesday, October 28, 2020NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Wednesday, October 28, 2020REFUSAL PROCESSED BY MPU
Tuesday, October 27, 2020NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Monday, October 26, 2020NON-FINAL ACTION WRITTEN
Friday, October 23, 2020NON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW
Thursday, October 1, 2020NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Wednesday, September 30, 2020NON-FINAL ACTION WRITTEN
Wednesday, September 30, 2020NON-FINAL ACTION WRITTEN
Sunday, September 27, 2020ASSIGNED TO EXAMINER
Tuesday, September 15, 2020APPLICATION FILING RECEIPT MAILED
Friday, September 11, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, September 8, 2020LIMITATION FROM ORIGINAL APPLICATION ENTERED
Thursday, September 3, 2020SN ASSIGNED FOR SECT 66A APPL FROM IB